Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Auna SA (AUNA), a dynamic player in the healthcare sector, stands out with a promising outlook for individual investors, marked by a remarkable potential upside nearing 100%. Situated in the..
Tectonic Therapeutic, Inc. (NASDAQ: TECX), a pioneering company in the biotechnology sector, is capturing investor attention with its innovative approach to developing therapeutic proteins and antibodies targeting G protein-coupled receptors..
Sage Therapeutics, Inc. (NASDAQ: SAGE) has garnered attention in the biotechnology sector, standing out with a notable potential upside of 24.44% according to analyst consensus. This Cambridge, Massachusetts-based biopharmaceutical company..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a significant player in the biotechnology industry, has captured investor interest with an eye-catching potential upside of 123.70% based on current analyst ratings. With..
Abivax SA (ABVX), a prominent player in the biotechnology sector, presents a compelling opportunity for investors with a potential upside of 429.10%, according to analyst ratings. This French company is..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is making waves in the biotechnology sector with a compelling proposition for investors looking for high-growth potential in the healthcare space. With its innovative approach..
Investors with an eye on the biotechnology sector may find PureTech Health plc (NASDAQ: PRTC) an intriguing prospect. Based in Boston, Massachusetts, PureTech Health specializes in the development and commercialization..
Surmodics, Inc. (NASDAQ: SRDX) stands at a pivotal junction within the healthcare sector, specifically in the burgeoning field of medical devices. As a company that has been in operation since..
Treace Medical Concepts, Inc. (NASDAQ: TMCI), a dynamic player in the healthcare sector, specializes in revolutionary medical devices aimed at addressing orthopedic challenges. With a market capitalization of approximately $369.25..
InnovAge Holding Corp. (NASDAQ: INNV) presents an intriguing opportunity for investors looking to tap into the healthcare sector, specifically within the niche of medical care facilities for seniors. With a..
Sionna Therapeutics, Inc. (NASDAQ: SION) is drawing significant attention in the biotechnology sector, particularly for investors looking to capitalize on the burgeoning field of cystic fibrosis treatment. With a market..
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a notable potential upside of 289.14%, according to analyst ratings. This San Diego-based..
Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector specializing in home health and hospice services, has been drawing the attention of investors amid its recent stock movements..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is gaining significant attention in the healthcare sector due to its innovative approach to cancer treatment. With a market cap of $475.6..
Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is gaining attention in the healthcare sector with its innovative approach to treating diseases with high unmet medical needs. With a..
Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $513.17 million, this U.S.-based company is carving..
REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company, has piqued investor interest with its promising pipeline and remarkable potential upside. With a market capitalization of $511.64 million, the company is..
Septerna, Inc. (NASDAQ: SEPN) stands out in the biotechnology sector with an intriguing investment profile, underscored by a potential upside of 127.35% according to the average analyst target price. Headquartered..
MeiraGTx Holdings plc (NASDAQ: MGTX) offers a compelling opportunity for investors seeking exposure to the burgeoning field of genetic medicine. Specializing in the development of transformative treatments for serious diseases,..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a dynamic player in the biotechnology sector, is capturing significant attention from investors, particularly with its potential upside of over 102%. Operating at the cutting..
